Recall365
Recalls › Australia › BioCeuticals ArmaForce 30, 60 & 120 tablets and BioCeutical…

BioCeuticals ArmaForce 30, 60 & 120 tablets and BioCeuticals Clinical ImmuneForce 60 tablets — recall

Health products · Australia · 2026-10-08

BioCeuticals ArmaForce and Clinical ImmuneForce, allergic reaction risk

→ See all BioCeuticals recalls

CountryAustralia
CategoryHealth products
Published2026-10-08
BrandBioCeuticals
CompanyFIT-BioCeuticals Pty Ltd
Batch / expiryMultiple lot numbers (All lots not expired as of 08/10/2026)
Product typeMedicine
Registration no. (ARTG)299066, 340712
Recall levelConsumer
Hazard classClass I
ReasonSince 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis. However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines. Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no lon…
Recall typeRecall
RemedyWholesalers, distributors, pharmacies, retailers: • Inspect their stock immediately and quarantine affected stock on hand to prevent further use. • Return the completed Customer Acknowledgement and Stock Declaration Form within five business days, even if they do not have any affected stock. • Notify any downstream commercial customers to whom they have supplied the affected stock and instruct them to immediate cease supply and follow the recall instructions. • After submitting the Acknowledgement and Stock Declaration Form, prepare stock for return in accordance with the instructions from Bi…
Affected areaAustralia
Recall numberRC-2026-RN-00743-1
Official noticeView source ↗

Get alerted when BioCeuticals has another recall

Free: we'll email you when BioCeuticals appears in a new official recall across 11 markets, including the US, EU and Japan.

Watch BioCeuticals recalls — free →

What this means for sellers

Likely platform / channel actionsRetailers/importers typically pull and return stock; similar products may face tighter border checks.
Self-check for comparable productsCheck your comparable products' design, materials and QC records against the defect described here.
Rules & standards likely involvedthe destination market's product-safety rules and mandatory standards

🚨 Delisted or named by a regulator? Leave your details and situation — we'll assess and get back to you. Contact us →

General guidance only — not compliance or legal advice; the official notice and applicable law prevail.

Stay ahead of recalls like this

Get overseas recalls that matter to you (China-origin highlighted) + top hazards — one email a week. Free, unsubscribe anytime.

By subscribing you agree to our Privacy Policy & Terms (incl. cross-border data processing).

Or search & set alerts — free →

Related health products recalls